ClinicalTrials.Veeva

Menu

Validation of Walking and Remembering Test

E

Emre Şenocak

Status

Completed

Conditions

Healthy Individuals

Treatments

Other: Walking and Remembering Test

Study type

Interventional

Funder types

Other

Identifiers

NCT06580171
25.07.2024/112

Details and patient eligibility

About

In this study, the usability of the Walking and Remembering Test will be examined using the remote interview method. The study will be carried out with a single group. First, the WART test will be performed face-to-face at Marmara University Biomechanics Laboratory. The second evaluation will be carried out using a remote method. From the participants;

  • He/she will first be asked to walk freely within a line that is 8 meters long and 19 cm wide. Later;
  • He will be asked to walk once at average speed and three times as fast as possible in the same line. Later;
  • The participant is given a Counting Test. This test includes number sequences from 4 digits to 9 digits. Participants are told these number strings and asked to repeat them with the same speed and tone of voice. The longest sequence of numbers is recorded. Later;
  • The participant is walked on the same line again and asked to repeat the longest number sequence he remembers and the test is completed. Cognitive performance with the counting test reflects walking speed during 4 walks, and the number of incorrect steps reflects walking performance.

Enrollment

30 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Having any known psychological, vestibular and neurological diseases,
  • No major or minor hip, knee or ankle injuries,
  • Not showing osteoarticular or muscle traumas that prevent upright posture and ambulation,
  • Not taking medications that affect posture, such as vestibular apparatus sedatives, antidepressants or anxiolytics,
  • Not complaining of dizziness or vertigo,
  • Being between the ages of 18-30.

Exclusion criteria

  • Individuals with untreated visual impairment,
  • Epilepsy, postural dizziness or hypotension,
  • Individuals with dependent ambulation,
  • Individuals with any disease that affects balance,
  • Those with cancer or fibromyalgia.

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Walking and Remembering Group
Experimental group
Description:
Only Walking and Remembering Test will be applied to the group.
Treatment:
Other: Walking and Remembering Test

Trial contacts and locations

1

Loading...

Central trial contact

Emre Şenocak, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems